News
23h
MedPage Today on MSNPre-Op Osimertinib in Lung Cancer Leads to More Major Pathologic ResponsesNeoadjuvant osimertinib (Tagrisso) with or without chemotherapy significantly increased major pathologic response (MPR) rates ...
College of Chemistry and Materials Science, International Joint Laboratory on Resource Chemistry of Ministry Education, Shanghai Normal University, Shanghai 200234, P. R. China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results